Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 177

Results For "IT"

10301 News Found

Evolving digital landscape within India's healthcare sector: HealthComms 2024 Report
Digitisation | February 22, 2024

Evolving digital landscape within India's healthcare sector: HealthComms 2024 Report

These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields


Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
Policy | February 22, 2024

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students

We are achieving the target of developed India by making our young children healthy today


Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur
News | February 21, 2024

Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur

The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today


AstraZeneca completes acquisition of Icosavax
News | February 21, 2024

AstraZeneca completes acquisition of Icosavax

The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus


European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis
Drug Approval | February 20, 2024

European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis

VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU


Biocon included in S&P Global Sustainability Yearbook 2024
Sustainability | February 20, 2024

Biocon included in S&P Global Sustainability Yearbook 2024

Sustainability is integral to Biocon's business purpose


GSK completes acquisition of Aiolos Bio
News | February 19, 2024

GSK completes acquisition of Aiolos Bio

The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody


Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery
News | February 18, 2024

Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery

Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery


Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP
Drug Approval | February 17, 2024

Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP

Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)